Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Ideal & Hightech Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company maintains a strong focus on central nervous system (CNS) therapeutics, producing a variety of treatments for conditions such as schizophrenia, depression, and anxiety. With multiple GMP-certified production lines, the firm operates as a significant supplier within the domestic Chinese market while also engaging in international trade. Their portfolio includes well-established generic medications alongside efforts in modernized pharmaceutical manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Ideal & Hightech Pharmaceutical.